![John Sundy](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Sundy
Directeur/Membre du Conseil chez
SANOFI
Profil
Dr. John Sundy is an Independent Director at Sanofi and a Chief Medical Officer at Seismic Therapeutic, Inc. He is on the Board of Directors at Sanofi, Childhood Arthritis & Rheumatology Research Alliance and Neutrolis, Inc. Dr. Sundy was previously employed as a Chief Medical Officer by Pandion Therapeutics, Inc., a Senior Vice President by Gilead Sciences, Inc., an Associate Professor by Duke University, and an Associate Professor by Duke-NUS Graduate Medical School Singapore.
He received his undergraduate degree from Bucknell University, a doctorate degree from Hahnemann University and a doctorate degree from Drexel University College of Medicine.
Postes actifs de John Sundy
| Sociétés | Poste | Début |
|---|---|---|
| SANOFI | Directeur/Membre du Conseil | 30/04/2024 |
Seismic Therapeutic, Inc.
 Seismic Therapeutic, Inc. Packaged SoftwareTechnology Services Develops machine learning immunology therapies | Directeur Technique/Scientifique/R&D | 01/01/2022 |
Neutrolis, Inc.
 Neutrolis, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for autoimmune and inflammatory diseases | Directeur/Membre du Conseil | 01/01/2022 |
Childhood Arthritis & Rheumatology Research Alliance | Directeur/Membre du Conseil | - |
Anciens postes connus de John Sundy
| Sociétés | Poste | Fin |
|---|---|---|
| PANDION THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/01/2021 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01/04/2020 |
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/2014 |
Duke-NUS Graduate Medical School Singapore
 Duke-NUS Graduate Medical School Singapore Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/2014 |
Formation de John Sundy
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
94
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Duke University
Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bucknell University
 Bucknell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hahnemann University
 Hahnemann University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Duke-NUS Graduate Medical School Singapore
Duke-NUS Graduate Medical School Singapore Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Drexel University College of Medicine
 Drexel University College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pandion Therapeutics, Inc.
 Pandion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company which develops novel therapeutics for autoimmune diseases | Health Technology |
Neutrolis, Inc.
Neutrolis, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for autoimmune and inflammatory diseases | Health Technology |
Seismic Therapeutic, Inc.
Seismic Therapeutic, Inc. Packaged SoftwareTechnology Services Develops machine learning immunology therapies | Technology Services |
Childhood Arthritis & Rheumatology Research Alliance |
